Reuters logo
2 months ago
BRIEF-Grifols' unit to initiate phase II clinical trials of Alzheimer's vaccine
June 27, 2017 / 9:52 AM / 2 months ago

BRIEF-Grifols' unit to initiate phase II clinical trials of Alzheimer's vaccine

June 27 (Reuters) - GRIFOLS SA:

* SAYS ITS UNIT ARACLON BIOTECH RECEIVES APPROVAL TO INITIATE PHASE II CLINICAL TRIALS OF ITS ALZHEIMER'S VACCINE Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below